{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:11:52Z","timestamp":1780575112234,"version":"3.54.1"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Bipolar disorder (BD) is a severe psychiatric disorder characterized by recurrent episodes of manic\/hypomanic or depressive symptoms and euthymic periods, with some patients suffering a gradual deterioration of illness and consequent cognitive deficits during the late stage. Migraine is a disease generally without abnormal medical examinations, neurological examinations or laboratory studies, and the diagnosis is made based on the retrospective demonstration of headache features and groupings of disease-associated symptoms. The epidemiology of comorbid BD and migraine is high and it is obligatory to find effective treatments to improve the prognosis. Recent investigations demonstrated that the close relationship between BD and migraine significantly increased the rapid cycling rates of both BD and migraine in patients. Although the detailed mechanism is complex and largely unclear in comorbid BD and migrain, genetic factors, neurotransmitters, altered signaling pathways, disturbances of inflammatory cytokines, and mitochondrial dysfunction are risk factors of BD and migraine. Particularly these two diseases share some overlapping mechanisms according to previous studies. To this end, we call for further investigations of the potential mechanisms, and more efforts are underway to improve the treatment of people with comorbid BD and migraine. In this review, we provide an overview of the potential mechanisms in patients with BD or migraine and we further discuss the treatment strategies for comorbid BD and migraine and it is obligatory to find effective treatments to improve the prognosis. This work will provide insights for us to know more about the mechanisms of comorbid BD and migraine, provides new therapeutic targets for the treatment and give clinicians some guidance for more appropriate and beneficial treatment.<\/jats:p>","DOI":"10.3389\/fpsyt.2020.560138","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T07:22:11Z","timestamp":1610436131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment"],"prefix":"10.3389","volume":"11","author":[{"given":"Jinfeng","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1586\/ern.09.31","article-title":"Clinical implications of a staging model for bipolar disorders","volume":"9","author":"Kapczinski","year":"2009","journal-title":"Expert Rev Neurother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1399-5618.2003.00091.x","article-title":"A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders","volume":"6","author":"Joffe","year":"2004","journal-title":"Bipolar Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1001\/archgenpsychiatry.2011.113","article-title":"Absolute risk of suicide after first hospital contact in mental disorder","volume":"68","author":"Nordentoft","year":"2011","journal-title":"Arch Gen Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1474-4422(06)70348-9","article-title":"Chronic disorders with episodic manifestations: focus on epilepsy and migraine","volume":"5","author":"Haut","year":"2006","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1526-4610.2006.00404.x","article-title":"Workplace absenteeism and aspects of access to health care for individuals with migraine headache","volume":"46","author":"Lofland","year":"2006","journal-title":"Headache."},{"key":"B8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4088\/PCC.08m00728","article-title":"Migraine headache in affectively ill latino adults of mexican american origin is associated with bipolarity","volume":"11","author":"Dilsaver","year":"2009","journal-title":"Prim Care Comp J Clin Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1526-4610.1998.3802087.x","article-title":"Medical consultation for migraine: results from the American Migraine Study","volume":"38","author":"Lipton","year":"1998","journal-title":"Headache."},{"key":"B10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11920-018-0897-8","article-title":"Medical comorbidities in bipolar disorder","volume":"20","author":"Sinha","year":"2018","journal-title":"Curr Psychiatry Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1017\/S1092852915000929","article-title":"Comorbidity between neurological illness and psychiatric disorders","volume":"21","author":"Hesdorffer","year":"2016","journal-title":"CNS Spectr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1526-4610.2006.00469.x","article-title":"The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey","volume":"46","author":"McIntyre","year":"2006","journal-title":"Headache."},{"key":"B13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jad.2015.01.024","article-title":"Rapid cycling as a feature of bipolar disorder and comorbid migraine","volume":"175","author":"Gordon-Smith","year":"2015","journal-title":"J Affect Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00127-019-01755-1","article-title":"Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016","volume":"55","author":"Jeyagurunathan","year":"2020","journal-title":"Soc Psychiatry Psychiatr Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.001","article-title":"CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease","volume":"99","author":"Bhat","year":"2012","journal-title":"Prog Neurobiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e39955","DOI":"10.1371\/journal.pone.0039955","article-title":"Gamma band neural synchronization deficits for auditory steady state responses in bipolar disorder patients","volume":"7","author":"Oda","year":"2012","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainresrev.2004.02.003","article-title":"Critical role of brain-derived neurotrophic factor in mood disorders","volume":"45","author":"Hashimoto","year":"2004","journal-title":"Brain Res Brain Res Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2007.01.002","article-title":"Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder","volume":"415","author":"Walz","year":"2007","journal-title":"Neurosci Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J Affect Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J Psychiatr Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J Affect Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","article-title":"Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder","volume":"166","author":"Bai","year":"2014","journal-title":"J Affect Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0165-0327(93)90097-4","article-title":"Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy","volume":"27","author":"Kato","year":"1993","journal-title":"J Affect Disord."},{"key":"B26","first-page":"189","article-title":"Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder","volume":"31","author":"Sun","year":"2006","journal-title":"J Psychiatry Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.schres.2007.01.030","article-title":"DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia","volume":"93","author":"Buttner","year":"2007","journal-title":"Schizophr Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.neuint.2009.05.003","article-title":"Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain","volume":"55","author":"Riegel","year":"2009","journal-title":"Neurochem Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","article-title":"Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia","volume":"11","author":"Wang","year":"2009","journal-title":"Bipolar Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia","volume":"32","author":"Kunz","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.pnpbp.2009.06.005","article-title":"Oxidative imbalance in bipolar disorder subtypes: a comparative study","volume":"33","author":"Yumru","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","article-title":"DNA damage in bipolar disorder","volume":"153","author":"Andreazza","year":"2007","journal-title":"Psychiatry Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/386824a0","article-title":"Subgenual prefrontal cortex abnormalities in mood disorders","volume":"386","author":"Drevets","year":"1997","journal-title":"Nature."},{"key":"B34","doi-asserted-by":"publisher","first-page":"13290","DOI":"10.1073\/pnas.95.22.13290","article-title":"Glial reduction in the subgenual prefrontal cortex in mood disorders","volume":"95","author":"Ongur","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-014-1806-z","article-title":"Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia","volume":"357","author":"Berridge","year":"2014","journal-title":"Cell Tissue Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/jamapsychiatry.2014.176","article-title":"Identification of pathways for bipolar disorder: a meta-analysis","volume":"71","author":"Nurnberger","year":"2014","journal-title":"JAMA Psychiatry."},{"key":"B37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nn.3922","article-title":"Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways","volume":"18","author":"Network","year":"2015","journal-title":"Nat Neurosci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1586\/14737175.8.7.1101","article-title":"Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder","volume":"8","author":"Kapczinski","year":"2008","journal-title":"Expert Rev Neurother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/15622975.2018.1500033","article-title":"Adiponectin is decreased in bipolar depression","volume":"20","author":"Platzer","year":"2019","journal-title":"World J Biol Psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1034\/j.1399-5618.2000.020305.x","article-title":"Mitochondrial dysfunction in bipolar disorder","volume":"2","author":"Kato","year":"2000","journal-title":"Bipolar Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1023\/A:1010955807739","article-title":"Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity","volume":"26","author":"Calabrese","year":"2001","journal-title":"Neurochem Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","article-title":"Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4","volume":"87","author":"Ophoff","year":"1996","journal-title":"Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.bbadis.2012.04.008","article-title":"Familial hemiplegic migraine type 1 mutations W1684R and V1696I alter G protein-mediated regulation of Ca(V)2.1 voltage-gated calcium channels","volume":"1822","author":"Garza-Lopez","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/ng1081","article-title":"Haploinsufficiency of ATP1A2 encoding the Na+\/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2","volume":"33","author":"De Fusco","year":"2003","journal-title":"Nat Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0140-6736(05)66786-4","article-title":"Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine","volume":"366","author":"Dichgans","year":"2005","journal-title":"Lancet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21994","article-title":"Thalamic sensitization transforms localized pain into widespread allodynia","volume":"68","author":"Burstein","year":"2010","journal-title":"Ann Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1526-4610.2005.05135.x","article-title":"Plasma cytokine levels in migraineurs and controls","volume":"45","author":"Perini","year":"2005","journal-title":"Headache."},{"key":"B48","first-page":"245","article-title":"An overview on immune system and migraine","volume":"11","author":"Bruno","year":"2007","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nurt.2010.03.006","article-title":"Nitric oxide-related drug targets in headache","volume":"7","author":"Olesen","year":"2010","journal-title":"Neurotherapeutics."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1468-1331.2011.03414.x","article-title":"Oxidative stress is associated with migraine and migraine-related metabolic risk in females","volume":"18","author":"Bernecker","year":"2011","journal-title":"Eur J Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/0333102414564888","article-title":"A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine","volume":"35","author":"Neri","year":"2015","journal-title":"Cephalalgia."},{"key":"B52","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1468-2982.2003.00705.x","article-title":"Flunarizine effects on oxidative stress in migraine patients","volume":"24","author":"Ciancarelli","year":"2004","journal-title":"Cephalalgia."},{"key":"B53","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/head.12021","article-title":"Headache currents commentary","volume":"53","author":"Burch","year":"2013","journal-title":"Headache."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1177\/0333102420929023","article-title":"Dopaminergic symptoms in migraine: a cross-sectional study on 1148 consecutive headache center-based patients","volume":"40","author":"Barbanti","year":"2020","journal-title":"Cephalalgia."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/archneur.62.8.1270","article-title":"A positron emission tomographic study in spontaneous migraine","volume":"62","author":"Afridi","year":"2005","journal-title":"Arch Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pain.2013.07.021","article-title":"Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain","volume":"154","author":"Noseda","year":"2013","journal-title":"Pain."},{"key":"B57","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1212\/01.CON.0000418640.07405.31","article-title":"Migraine diagnosis and pathophysiology","volume":"18","author":"Ward","year":"2012","journal-title":"Continuum."},{"key":"B58","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.2174\/092986732634191112142448","article-title":"Biomarkers in migraine headache: prognostic and therapeutic implications","volume":"26","author":"Ferroni","year":"2019","journal-title":"Curr Med Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10072-018-3356-8","article-title":"Bipolar disorder and chronic migraine: an open problem","volume":"39","author":"Di Marco","year":"2018","journal-title":"Neurol Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jad.2016.07.034","article-title":"Parental and comorbid migraine in individuals with bipolar disorder: a nationwide register study","volume":"206","author":"Sucksdorff","year":"2016","journal-title":"J Affect Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0327(00)00226-3","article-title":"Serotonin and bipolar disorder","volume":"66","author":"Mahmood","year":"2001","journal-title":"J Affect Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/0333102416640501","article-title":"Serotonergic mechanisms in the migraine brain - a systematic review","volume":"37","author":"Deen","year":"2017","journal-title":"Cephalalgia."},{"key":"B63","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s13311-017-0599-7","article-title":"Correction to: migraine treatment: current acute medications and their potential mechanisms of action","volume":"15","author":"Ong","year":"2018","journal-title":"Neurotherapeutics."},{"key":"B64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pscychresns.2015.05.010","article-title":"Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder","volume":"233","author":"Ehrlich","year":"2015","journal-title":"Psychiatry Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1468-2982.2006.01234.x","article-title":"Platelet glutamate uptake and release in migraine with and without aura","volume":"27","author":"Vaccaro","year":"2007","journal-title":"Cephalalgia."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/0333102418807182","article-title":"Leptin, adiponectin, and resistin blood adipokine levels in migraineurs: systematic reviews and meta-analyses","volume":"39","author":"Abbasi","year":"2019","journal-title":"Cephalalgia."},{"key":"B67","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.neuron.2018.03.017","article-title":"Calcium channels, synaptic plasticity, neuropsychiatric disease","volume":"98","author":"Nanou","year":"2018","journal-title":"Neuron."},{"key":"B68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jad.2009.06.014","article-title":"A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11","volume":"122","author":"Oedegaard","year":"2010","journal-title":"J Affect Disord."},{"key":"B69","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1526-4610.2011.01858.x","article-title":"No association between bipolar disorder risk polymorphisms in ANK3 and CACNA1C and common migraine","volume":"51","author":"Wober-Bingol","year":"2011","journal-title":"Headache."},{"key":"B70","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1601-183X.2010.00601.x","article-title":"A genome-wide association study of bipolar disorder and comorbid migraine","volume":"9","author":"Oedegaard","year":"2010","journal-title":"Genes Brain Behav."},{"key":"B71","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/bdi.12347","article-title":"Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder","volume":"17","author":"Rolstad","year":"2015","journal-title":"Bipolar Disord."},{"key":"B72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","article-title":"An updated meta-analysis of oxidative stress markers in bipolar disorder","volume":"218","author":"Brown","year":"2014","journal-title":"Psychiatry Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci Biobehav Rev."},{"key":"B74","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fnmol.2017.00320","article-title":"Connexin43- and pannexin-based channels in neuroinflammation and cerebral neuropathies","volume":"10","author":"Sarrouilhe","year":"2017","journal-title":"Front Mol Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1399-5618.2007.00444.x","article-title":"An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment","volume":"9","author":"Knijff","year":"2007","journal-title":"Bipolar Disord."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/head.12174","article-title":"Biomarkers associated with migraine and their potential role in migraine management","volume":"53","author":"Durham","year":"2013","journal-title":"Headache."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(13)60989-7","article-title":"Bipolar disorder diagnosis: challenges and future directions","volume":"381","author":"Phillips","year":"2013","journal-title":"Lancet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/acps.12133","article-title":"Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis","volume":"128","author":"Bourne","year":"2013","journal-title":"Acta Psychiatr Scand."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.pnpbp.2009.07.027","article-title":"The potential use of biomarkers as an adjunctive tool for staging bipolar disorder","volume":"33","author":"Kapczinski","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1192\/bjp.bp.114.158543","article-title":"Mood instability: significance, definition and measurement","volume":"207","author":"Broome","year":"2015","journal-title":"Br J Psychiatry."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1176\/ajp.152.11.1635","article-title":"Relapse and impairment in bipolar disorder","volume":"152","author":"Gitlin","year":"1995","journal-title":"Am J Psychiatry."},{"key":"B83","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.psyneuen.2008.10.006","article-title":"The effects of TNF deficiency on age-related cognitive performance","volume":"34","author":"McAfoose","year":"2009","journal-title":"Psychoneuroendocrinology."},{"key":"B84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1874467210902020207","article-title":"Mood-stabilizers target the brain arachidonic acid cascade","volume":"2","author":"Rao","year":"2009","journal-title":"Curr Mol Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.plefa.2009.10.007","article-title":"Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder","volume":"82","author":"Stolk","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"B86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jpsychires.2013.11.011","article-title":"Oxidative stress in early stage bipolar disorder and the association with response to lithium","volume":"50","author":"de Sousa","year":"2014","journal-title":"J Psychiatr Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2009.03.022","article-title":"Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells","volume":"455","author":"Bakare","year":"2009","journal-title":"Neurosci Lett."},{"key":"B88","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1111\/j.1526-4610.2006.00563.x","article-title":"Basic principles and techniques of cognitive-behavioral therapies for comorbid psychiatric symptoms among headache patients","volume":"46","author":"Lipchik","year":"2006","journal-title":"Headache."},{"key":"B89","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0317167100017819","article-title":"Canadian Headache Society Guideline: acute drug therapy for migraine headache","volume":"40","author":"Worthington","year":"2013","journal-title":"Can J Neurol Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1526-4610.2006.00691.x","article-title":"The serotonin syndrome, triptans, and the potential for drug-drug interactions","volume":"47","author":"Shapiro","year":"2007","journal-title":"Headache."},{"key":"B91","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0317167100015109","article-title":"Canadian Headache Society guideline for migraine prophylaxis","volume":"39","author":"Pringsheim","year":"2012","journal-title":"Can J Neurol Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e12663","DOI":"10.1111\/jpi.12663","article-title":"The association between melatonin and episodic migraine: a pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy","volume":"69","author":"Tseng","year":"2020","journal-title":"J Pineal Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jad.2020.01.151","article-title":"Evening chronotype as a discrete clinical subphenotype in bipolar disorder","volume":"266","author":"Romo-Nava","year":"2020","journal-title":"J Affect Disord."},{"key":"B94","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0333102416657145","article-title":"Follow-up over 20 months confirms gains of online behavioural training in frequent episodic migraine","volume":"37","author":"Sorbi","year":"2017","journal-title":"Cephalalgia."},{"key":"B95","doi-asserted-by":"publisher","first-page":"138","DOI":"10.15441\/ceem.16.199","article-title":"Single-dose intravenous sodium valproate (Depakine) vs. dexamethasone for the treatment of acute migraine headache: a double-blind randomized clinical trial","volume":"4","author":"Karimi","year":"2017","journal-title":"Clin Exp Emerg Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.genhosppsych.2015.07.001","article-title":"Medical comorbidity, acute medical care use in late-life bipolar disorder: a comparison of lithium, valproate, other pharmacotherapies","volume":"37","author":"Rej","year":"2015","journal-title":"Gen Hosp Psychiatry."},{"key":"B97","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jad.2010.09.009","article-title":"A pharmaco-epidemiological study of migraine and antidepressant medications: complete one year data from the Norwegian population","volume":"129","author":"Oedegaard","year":"2011","journal-title":"J Affect Disord."},{"key":"B98","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1046\/j.1526-4610.2003.03184.x","article-title":"Prevalence, clinical correlates, and treatment of migraine in bipolar disorder","volume":"43","author":"Low","year":"2003","journal-title":"Headache."},{"key":"B99","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/JCP.0b013e318235f4e9","article-title":"Are migraine and bipolar disorders comorbid phenomena?: findings from a pharmacoepidemiological study using the Norwegian Prescription Database","volume":"31","author":"Oedegaard","year":"2011","journal-title":"J Clin Psychopharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra035354","article-title":"Bipolar disorder","volume":"351","author":"Belmaker","year":"2004","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1517\/14656566.2014.929665","article-title":"Sodium channel antagonists for the treatment of migraine","volume":"15","author":"Chiossi","year":"2014","journal-title":"Exp Opin Pharmacother."},{"key":"B102","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.sjpain.2015.12.002","article-title":"Migraine headache and bipolar disorder comorbidity: a systematic review of the literature and clinical implications","volume":"11","author":"Leo","year":"2016","journal-title":"Scand J Pain."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e55100","DOI":"10.3791\/55100","article-title":"How to use the H1 deep transcranial magnetic stimulation coil for conditions other than depression","volume":"119","author":"Tendler","year":"2017","journal-title":"J Vis Exp."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.3390\/ijms20194737","article-title":"Leptin and associated mediators of immunometabolic signaling: novel molecular outcome measures for neurostimulation to treat chronic pain","volume":"20","author":"Kinfe","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.brs.2019.01.008","article-title":"Inter-ictal assay of peripheral circulating inflammatory mediators in migraine patients under adjunctive cervical non-invasive vagus nerve stimulation (nVNS): a proof-of-concept study","volume":"12","author":"Chaudhry","year":"2019","journal-title":"Brain Stimul."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.560138\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:38:14Z","timestamp":1610584694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.560138\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":105,"alternative-id":["10.3389\/fpsyt.2020.560138"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.560138","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"article-number":"560138"}}